- Adults
 - General population
 - Elderly
 - SARS-CoV-2
 - Post-COVID-19
 - Non pharmacological intervention
 - Immunoadsorption
 
Population: Adults
Individuals aged 18-64 years
- Adults
 - General population
 - Elderly
 - SARS-CoV-2
 - Post-COVID-19
 - Non pharmacological intervention
 - Rehabilitation
 - Vimida
 
- Adults
 - General population
 - Hospital wide
 - SARS-CoV-2
 - Post-COVID-19
 
- Adults
 - General population
 - People at high risk of STIs
 - Outpatient clinic
 - Non-hospital health centre
 - STD/STI clinic
 - Monkeypox virus
 - Monkeypox virus infection
 
- Adults
 - General population
 - Elderly
 - Outpatient clinic
 - SARS-CoV-2
 - Post-COVID-19
 - Non pharmacological intervention
 - Rehabilitation
 
- Adults
 - Fragile population
 - People at high risk of STIs
 - Immunocompromised host
 - Men who have sex with men
 - People living with HIV
 - Hospital wide
 - Monkeypox virus
 - Monkeypox virus infection
 
- Adults
 - General population
 - SARS-CoV-2
 - Post-COVID-19
 - Non pharmacological intervention
 - Rehabilitation
 - Neurostimulation
 
- Adults
 - General population
 - Elderly
 - Paediatric
 - Hospital wide
 - Outpatient clinic
 - Monkeypox virus
 - Monkeypox virus infection
 
- Adults
 - General population
 - Monkeypox virus
 - Monkeypox virus infection
 - Pharmacological intervention
 - Vaccination
 - VAC∆6
 
- Adults
 - General population
 - Elderly
 - Primary care
 - SARS-CoV-2
 - Post-COVID-19
 - Non pharmacological intervention
 - Hydroxy gas
 
- Adults
 - General population
 - Hospital wide
 - Outpatient clinic
 - Monkeypox virus
 - Monkeypox virus infection
 
- Adults
 - General population
 - Hospital wide
 - Outpatient clinic
 - SARS-CoV-2
 - Post-COVID-19